Antibodies to heteromeric glycolipid complexes in Guillain-Barre syndrome

Antibodies to heteromeric glycolipid complexes in Guillain-Barre syndrome

Autoantibodies are infrequently detected in the sera of patients with the demyelinating form of Guillain-Barré syndrome most commonly encountered in the Western world, despite abundant circumstantial evidence suggesting their existence. We hypothesised that antibody specificities reliant on the cis...

Full description

Bibliographic Details
Main Authors:	Rinaldi, S, Brennan, K, Kalna, G, Walgaard, C, Van Doorn, P, Jacobs, B, Yu, R, Mansson, J, Goodyear, C, Willison, H
Format:	Journal article
Language:	English
Published:	Public Library of Science 2013

Similar Items

Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy
by: Galban-Horcajo, F, et al.
Published: (2013)

Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy.
by: Galban-Horcajo, F, et al.
Published: (2013)

Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding.
by: Rinaldi, S, et al.
Published: (2010)

Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome
by: Thomma, RCM, et al.
Published: (2025)

Regional variation of Guillain-Barré syndrome
by: Doets, AY, et al.
Published: (2018)

International Guillain-Barré Syndrome Outcome Study: Protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome
by: Jacobs, BC, et al.
Published: (2017)

Complex antibodies provide a simple explanation for the plurality of clinical presentations in the Guillain Barre syndromes.
by: Rinaldi, S
Published: (2015)

Regional variation of Guillain-Barre syndrome
by: Van Den Berg, B, et al.
Published: (2018)

Guillain‐Barré syndrome: A comprehensive review
by: Bellanti, R, et al.
Published: (2024)

Current treatment practice of Guillain-Barré syndrome
by: Verboon, Christine, et al.
Published: (2019)

International validation of the Erasmus Guillain–Barré syndrome respiratory insufficiency score
by: Doets, AY, et al.
Published: (2022)

Guillain-Barre syndrome with severe persistent disability: relationship to hyperacute Guillain-Barre syndrome.
by: Palace, J, et al.
Published: (1994)

Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays.
by: Rinaldi, S, et al.
Published: (2009)

Diabetes associated with Guillain-Barre syndrome.
by: Flax, H, et al.
Published: (1990)

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
by: Verboon, C, et al.
Published: (2021)

Risk of fracture in patients with Guillain-Barre syndrome.
by: Pouwels, S, et al.
Published: (2014)

Infectious and noninfectious triggers in Guillain-Barre syndrome.
by: Wakerley, B, et al.
Published: (2013)

Guillain-Barré-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies
by: Tüzün, E, et al.
Published: (2013)

Guillain-Barre-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies.
by: Tüzün, E, et al.
Published: (2013)

Guillain-Barré syndrome following Zika virus infection is associated with a diverse spectrum of peripheral nerve reactive antibodies
by: Davies, AJ, et al.
Published: (2022)

Surgery itself does not trigger Guillain-Barre syndrome.
by: Wakerley, B, et al.
Published: (2013)

Mimics and chameleons in Guillain-Barre and Miller Fisher syndromes.
by: Wakerley, B, et al.
Published: (2014)

Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome.
by: Wakerley, B, et al.
Published: (2014)

Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
by: Keddie, S, et al.
Published: (2020)

Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barré syndrome mouse model
by: McGonigal, R, et al.
Published: (2022)

The utility of Guillain‐Barré syndrome prognostic models in Malaysian patients
by: Tan, Cheng Yin, et al.
Published: (2019)

Peripheral neuropathies: Clinical prognostic scales in Guillain-Barré syndrome
by: Shahrizaila, N., et al.
Published: (2011)

The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action
by: Shahrizaila, N., et al.
Published: (2011)

Guillain-Barre and Miller Fisher syndromes--new diagnostic classification.
by: Wakerley, B, et al.
Published: (2014)

Guillain-Barre and Miller Fisher syndromes-new diagnostic classification.
by: Wakerley, B, et al.
Published: (2014)

Guillain-Barré syndrome following SARS-CoV-2 infection in the international GBS outcome study
by: Luijten, L, et al.
Published: (2021)

An international perspective on preceding infections in Guillain-Barré Syndrome: the IGOS-1000 cohort
by: Leonhard, SE, et al.
Published: (2022)

Guillain-Barre syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis: Understanding the pathogenesis
by: Shahrizaila, N., et al.
Published: (2010)

Seasonal variation, sub-type and prodromal illnesses in guillain-barre syndrome.
by: Brain, S, et al.
Published: (2013)

Re: "incidence of Guillain-Barre syndrome following infection with Campylobacter jejuni".
by: Weinberg, E
Published: (2001)

Seasonal variation in Guillain-Barre syndrome: a systematic review, meta-analysis and Oxfordshire cohort study.
by: Webb, A, et al.
Published: (2014)

Massive heterotopic ossification in Guillain-Barré Syndrome : a rare case report.
by: Ohnmar H.,, et al.
Published: (2010)

Erasmus Guillain-Barre Syndrome Outcome Score (EGOS) to predict functional outcomes
by: Ulfa, Maria, et al.
Published: (2022)

Anti-TNF-α therapy itself does not trigger Guillain-Barre syndrome.
by: Wakerley, B, et al.
Published: (2013)

Sensory predominant Guillain-Barré syndrome concomitant with dengue infection: A case report
by: Alvin Oliver Payus, et al.
Published: (2022)